Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Acne is a growing global health crisis, not just a teenage phase. A new analysis of the 2023 Global Burden of Disease study found that acne cases rose more than 67% between 1990 and 2023, reaching 54.4 million cases worldwide. Researchers project that number will climb even higher by 2050, with the burden rivaling conditions like melanoma and psoriasis.
Acne is a growing global health crisis, not just a teenage phase. A new cross-sectional analysis of the 2023 Global Burden of Disease (GBD) study, published in JAMA Dermatology, found that global acne cases surged more than 63% between 1990 and 2023, reaching 54.4 million cases worldwide. The condition accounted for 1.17 million disability-adjusted life-years (DALYs) — a disease burden comparable to squamous cell carcinoma and approaching that of melanoma and psoriasis.
Adolescents and young adults bore the heaviest burden, with females aged 15–19 showing the highest prevalence rates. Researchers used ARIMA forecasting models to project continued growth through 2050, driven by factors like dietary shifts toward high-carbohydrate foods and evolving diagnostic practices.
By the Numbers:
Why it matters: Acne is often dismissed as a cosmetic concern, but this data makes clear it carries a serious, measurable disease burden with lasting physical and psychological consequences. Experts are calling for greater investment in accessible, long-term treatments — and a shift in how treatment success is measured, beyond just clearing lesions to preventing scarring and improving quality of life.
